Ratings by Berenberg (Ravi Misra)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/1/2022 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 8/2/2022 | Teladoc | TDOC | Downgrade | Hold (Buy) |
36.81 (12.98) |
-64.74% | Details | |
| 6/16/2022 | Teladoc | TDOC | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2021 | Teladoc | TDOC | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2021 | Align Technology | ALGN | Upgrade | Buy (Hold) |
616.08 (298.98) |
-51.47% | Details | |
| 2/9/2021 | Masimo Corp. | MASI | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2020 | Nano-X Imaging | NNOX | New Coverage | Buy (N/A) |
49.21 (8.60) |
-82.52% | Details | |
| 9/2/2020 | Teladoc | TDOC | Upgrade | Buy (Hold) |
224.20 (12.98) |
-94.21% | Details | |
| 7/29/2020 | Align Technology | ALGN | Downgrade | Hold (Buy) |
299.11 (298.98) |
-0.04% | Details | |
| 3/31/2020 | Teladoc | TDOC | Downgrade | Hold (Buy) |
163.56 (12.98) |
-92.06% | Details | |
| 1/6/2020 | Glaukos Corporation | GKOS | Upgrade | Buy (Hold) |
54.49 (96.50) |
77.1% | Details | |
| 11/6/2019 | Inspire Medical Systems | INSP | Upgrade | Hold (Sell) |
60.56 (229.22) |
278.5% | Details | |
| 6/21/2019 | Intersect ENT | XENT | Downgrade | Hold (Buy) |
24.16 (28.24) |
16.89% | Details | |
| 4/17/2019 | Masimo Corp. | MASI | New Coverage | Buy (N/A) |
136.15 (134.77) |
-1.01% | Details | |
| 1/31/2019 | Teladoc | TDOC | New Coverage | Buy (N/A) |
60.76 (12.98) |
-78.64% | Details | |
| 11/28/2018 | Inspire Medical Systems | INSP | New Coverage | Sell (N/A) |
44.89 (60.56) |
34.91% | Details | |
| 8/30/2018 | Tandem Diabetes Care | TNDM | New Coverage | Buy (N/A) |
40.59 (30.43) |
-25.03% | Details | |
| 8/30/2018 | Glaukos Corporation | GKOS | New Coverage | Hold (N/A) |
44.80 (54.49) |
21.63% | Details |
